Advertisement
Advertisement

Leap Therapeutics Rebrands and Acquires Zcash Tokens

Story Highlights
  • Cypherpunk Technologies rebranded from Leap Therapeutics, focusing on digital assets and cancer therapies.
  • The company invested $50 million in Zcash and appointed new leadership to drive its strategic shift.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Leap Therapeutics Rebrands and Acquires Zcash Tokens

Meet Your ETF AI Analyst

Leap Therapeutics ( (LPTX) ) just unveiled an update.

On November 11, 2025, Cypherpunk Technologies Inc. announced a series of strategic changes, including a rebranding from Leap Therapeutics and the introduction of a digital asset treasury strategy. The company has used $50 million from a private placement led by Winklevoss Capital to acquire 203,775 Zcash tokens, aiming to enhance shareholder value through this investment. Additionally, Khing Oei and William McEvoy were appointed to the board, with McEvoy also serving as Chief Investment Officer, marking a significant leadership expansion. The company also announced a change in its Nasdaq ticker symbol to ‘CYPH’ effective November 13, 2025, reflecting its new strategic direction.

The most recent analyst rating on (LPTX) stock is a Hold with a $1.25 price target. To see the full list of analyst forecasts on Leap Therapeutics stock, see the LPTX Stock Forecast page.

Spark’s Take on LPTX Stock

According to Spark, TipRanks’ AI Analyst, LPTX is a Underperform.

Leap Therapeutics faces significant financial challenges with persistent losses and no revenue growth, resulting in a low financial performance score. The technical analysis suggests bearish trends with some potential for short-term volatility. The company’s valuation metrics are also unfavorable due to negative earnings. No recent earnings call or corporate events data are available to impact the score further.

To see Spark’s full report on LPTX stock, click here.

More about Leap Therapeutics

Cypherpunk Technologies Inc., formerly known as Leap Therapeutics, Inc., operates in the digital asset and biotechnology sectors. The company focuses on developing novel therapies for cancer patients and has recently implemented a digital asset treasury strategy centered on Zcash, a privacy-focused cryptocurrency.

Average Trading Volume: 3,541,541

Technical Sentiment Signal: Sell

Current Market Cap: $26.03M

For a thorough assessment of LPTX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1